KLRA
Kailera Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD18.41
+0.50 (+2.79%)
Rating:C
Company Profile
CEO
Ronald C. Renaud Jr.
IPO Date
2026-04-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$17.80
Prev. Close
$17.91
Day Low
$17.50
Day High
$18.59
52W Low
$17.50
52W High
$28.23
Market Cap
$2.39B
Volume
0.42M